Received May 13, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| SMALLMNK | SMALLPOX + MONKEYPOX (JYNNEOS) | BAVARIAN NORDIC | 1 | FDP00016 | IM / LA |
The treatment was the first of a two-series vaccination; the outcome was uneventful, with no symptoms or signs of reactions reported.
None reported
HIV WITHOUT previous history of AIDS defining illness(HCC) (HCC) History of hepatitis C Hepatitis B immune Pulmonary nodule Hypovitaminosis D Caffeine use Current every day vaping Seasonal allergies
bictegrav-emtricit-tenofov (BIKTARVY) 50-200-25 mg tab cholecalciferol (VITAMIN D3) 1,250 mcg (50,000 unit) capsule triamcinolone (KENALOG) 0.1 % ointment albuterol HFA (PROAIR HFA) 90 mcg/actuation inhaler
NKDA
N/A